KOL Engagement and Panning, KOL Opinion, KOL Insights Primary Market Research, Rare Disease Research & Knowledge
Thelansis has strong expertise in identifying, mapping, segmenting, and profiling of KOLs across therapy areas to collect most relevant KOL Insights/ KOL Opinion. KOL engagement right from the beginning of the product development process is the key success factor in Rare and ultra-rare indications. Global KOL Panel Management System; comprises directories of trial investigators, Researcher, Healthcare Practitioner (HCPs), Payers, Regulatory bodies, and speakers
Successful KOL identification is about identifying anyone with the potential to impact your work – clinicians, authors, speakers, nurses, tweeters, or the medics building cutting edge apps for their patients.
We’re confident in our ability & accuracy to identify the right people because we’ve spent years engineering every step of the KOL identification process and transforming what ‘KOL identification’ can do for you.
We also appreciate that our work is all about people. That’s why even the largest bucket of objective analytics in the world cannot circumvent the subjective nuances of KOL identification and influence.
So, whether your KOL identification requires a global programme, a national exercise, or an exploration of the emerging markets of tomorrow – we can help.
Because KOL identification is what we do, every single day.